Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Hinzpeter

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Cellular and Molecular Life Sciences : CMLS|October 7, 2024
Novel gain-of-function mutants identify a critical region within CFTR membrane-spanning domain 2 controlling cAMP-dependent and ATP-independent channel activationSolène Castanier, Ahmad Elbahnsi, Benoit Chevalier, et al.
Human Mutation|February 20, 2013
Combined computational-experimental analyses of CFTR exon strength uncover predictability of exon-skipping levelAbdel Aissat, Alix de Becdelièvre, Lisa Golmard, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 4, 2024
TLN468 changes the pattern of tRNA used to read through premature termination codons in CFTRSabrina Karri, David Cornu, Claudia Serot, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 20, 2025
CFTR correctors potentiate gating mutants causing cystic fibrosisSolène Castanier, Ahmad Elbahnsi, Benoit Chevalier, et al.
European Journal of Medicinal Chemistry|February 1, 2021
Modulators of CFTR. Updates on clinical development and future directionsEmmanuelle Bardin, Alexandra Pastor, Michaela Semeraro, et al.
Human Mutation|October 16, 2012
Alternative splicing of in-frame exon associated with premature termination codons: implications for readthrough therapiesAlexandre Hinzpeter, Abdel Aissat, Alix de Becdelièvre, et al.
ACS Applied Materials & Interfaces|June 26, 2026
Spray-Pyrolyzed Hollow and Yolk-Shell CeO<sub>2</sub> Nanocarriers with Tunable Structure for Redox-Responsive Delivery and Gene Rescue ApplicationsJalal Poostforooshan, Cléa Chesneau, Laurent Michely, et al.
International Journal of Biological Macromolecules|January 15, 2025
Synthesis and physico-chemical investigation of thiolated dextran derivative: Design and application of a redox-responsive drug delivery systemCléa Chesneau, Andréa Pelletier, Pierre Dubot, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 20, 2020
Exon identity influences splicing induced by exonic variants and in silico prediction efficacyNatacha Martin, Anne Bergougnoux, Nesrine Baatallah, et al.
The Journal of Physiology|November 11, 2021
Correlating genotype with phenotype using CFTR-mediated whole-cell Cl<sup>-</sup> currents in human nasal epithelial cellsSabrina Noel, Nathalie Servel, Aurélie Hatton, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Cellular and Molecular Life Sciences : CMLS|October 7, 2024
Novel gain-of-function mutants identify a critical region within CFTR membrane-spanning domain 2 controlling cAMP-dependent and ATP-independent channel activationSolène Castanier, Ahmad Elbahnsi, Benoit Chevalier, et al.
Human Mutation|February 20, 2013
Combined computational-experimental analyses of CFTR exon strength uncover predictability of exon-skipping levelAbdel Aissat, Alix de Becdelièvre, Lisa Golmard, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 4, 2024
TLN468 changes the pattern of tRNA used to read through premature termination codons in CFTRSabrina Karri, David Cornu, Claudia Serot, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 20, 2025
CFTR correctors potentiate gating mutants causing cystic fibrosisSolène Castanier, Ahmad Elbahnsi, Benoit Chevalier, et al.
European Journal of Medicinal Chemistry|February 1, 2021
Modulators of CFTR. Updates on clinical development and future directionsEmmanuelle Bardin, Alexandra Pastor, Michaela Semeraro, et al.
Human Mutation|October 16, 2012
Alternative splicing of in-frame exon associated with premature termination codons: implications for readthrough therapiesAlexandre Hinzpeter, Abdel Aissat, Alix de Becdelièvre, et al.
ACS Applied Materials & Interfaces|June 26, 2026
Spray-Pyrolyzed Hollow and Yolk-Shell CeO<sub>2</sub> Nanocarriers with Tunable Structure for Redox-Responsive Delivery and Gene Rescue ApplicationsJalal Poostforooshan, Cléa Chesneau, Laurent Michely, et al.
International Journal of Biological Macromolecules|January 15, 2025
Synthesis and physico-chemical investigation of thiolated dextran derivative: Design and application of a redox-responsive drug delivery systemCléa Chesneau, Andréa Pelletier, Pierre Dubot, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 20, 2020
Exon identity influences splicing induced by exonic variants and in silico prediction efficacyNatacha Martin, Anne Bergougnoux, Nesrine Baatallah, et al.
The Journal of Physiology|November 11, 2021
Correlating genotype with phenotype using CFTR-mediated whole-cell Cl<sup>-</sup> currents in human nasal epithelial cellsSabrina Noel, Nathalie Servel, Aurélie Hatton, et al.
Pageof 6